MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology…
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing…
July 28, 2025 12:24 ET | Source: Can-Fite BioPharma Ltd. $5.0 million upfront with up to an additional $10.0 million…
NEW YORK, July 16, 2025 /PRNewswire/ -- Via Transportation, Inc. today announced that it has confidentially submitted a draft registration…
July 15, 2025 16:36 ET | Source: Gain Therapeutics, Inc. BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics,…
Over the weekend Temerario with Revuelto and Urus SE, deliver the performance and theatre of Lamborghini’s full hybrid super sports…
July 09, 2025 16:16 ET | Source: Rhythm Pharmaceuticals, Inc. BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.…
July 08, 2025 21:36 ET | Source: Cogent Biosciences, Inc. WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE)…
June 27, 2025 17:50 ET | Source: Primeenergy Resources Corporation HOUSTON, June 27, 2025 (GLOBE NEWSWIRE) -- PrimeEnergy Resources Corporation…
WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new…